• 262 Citations
  • 9 h-Index
20122019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Fabio Castagnetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Dermoscopy Medicine & Life Sciences
Confocal Microscopy Medicine & Life Sciences
Fluorescence Microscopy Medicine & Life Sciences
Leukemia, Myeloid, Chronic Phase Medicine & Life Sciences
Merkel Cell Carcinoma Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Basal Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 262 Citations
  • 9 h-Index
  • 27 Article
  • 1 Chapter
  • 1 Letter

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

Caocci, G., Mulas, O., Abruzzese, E., Luciano, L., Iurlo, A., Attolico, I., Castagnetti, F., Galimberti, S., Sgherza, N., Bonifacio, M., Annunziata, M., Gozzini, A., Orlandi, E. M., Stagno, F., Binotto, G., Pregno, P., Fozza, C., Trawinska, M. M., De Gregorio, F., Cattaneo, D. & 10 others, Albano, F., Gugliotta, G., Baratè, C., Scaffidi, L., Elena, C., Pirillo, F., Scalzulli, E., La Nasa, G., Foà, R. & Breccia, M., 2019, In : Hematological Oncology. 37, 3, p. 296-302 7 p.

Research output: Contribution to journalArticle

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Efficace, F., Stagno, F., Iurlo, A., Breccia, M., Cottone, F., Bonifacio, M., Abruzzese, E., Castagnetti, F., Caocci, G., Crugnola, M., Capodanno, I., Martino, B., Tiribelli, M., Patriarca, A., Gozzini, A., Pregno, P., Saussele, S., Cascavilla, N., Fozza, C., Bergamaschi, M. & 3 others, Binotto, G., Vignetti, M. & Rosti, G., 2019, In : Leukemia.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Quality of Life
Confidence Intervals
Protein-Tyrosine Kinases
Therapeutics

Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Fava, C., Rege-Cambrin, G., Dogliotti, I., Cerrano, M., Berchialla, P., Dragani, M., Rosti, G., Castagnetti, F., Gugliotta, G., Martino, B., Gambacorti-Passerini, C., Abruzzese, E., Elena, C., Pregno, P., Gozzini, A., Capodanno, I., Bergamaschi, M., Crugnola, M., Bocchia, M., Galimberti, S. & 25 others, Rapezzi, D., Iurlo, A., Cattaneo, D., Latagliata, R., Breccia, M., Cedrone, M., Santoro, M., Annunziata, M., Levato, L., Stagno, F., Cavazzini, F., Sgherza, N., Giai, V., Luciano, L., Russo, S., Musto, P., Caocci, G., Sorà, F., Iuliano, F., Lunghi, F., Specchia, G., Pane, F., Ferrero, D., Baccarani, M. & Saglio, G., 2019, In : Haematologica. 104, 8, p. 1589-1596 8 p.

Research output: Contribution to journalArticle

Observational study of chronic myeloid leukemia italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Fava, C., Rege-Cambrin, G., Dogliotti, I., Cerrano, M., Berchialla, P., Dragani, M., Rosti, G., Castagnetti, F., Gugliotta, G., Martino, B., Gambacorti-Passerini, C., Abruzzese, E., Elena, C., Pregno, P., Gozzini, A., Capodanno, I., Bergamaschi, M., Crugnola, M., Bocchia, M., Galimberti, S. & 25 others, Rapezzi, D., Iurlo, A., Cattaneo, D., Latagliata, R., Breccia, M., Cedrone, M., Santoro, M., Annunziata, M., Levato, L., Stagno, F., Cavazzini, F., Sgherza, N., Giai, V., Luciano, L., Russo, S., Musto, P., Caocci, G., Sorà, F., Iuliano, F., Lunghi, F., Specchia, G., Pane, F., Ferrero, D., Baccarani, M. & Saglio, G., 2019, In : Haematologica. 104, 8, p. 1589-1596 8 p.

Research output: Contribution to journalArticle

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D’Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., 2019, In : Annals of Hematology.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Germany